{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:32:39Z","timestamp":1793071959139,"version":"4.5.0"},"reference-count":264,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00239172"],"award-info":[{"award-number":["RS-2023-00239172"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202209307001"],"award-info":[{"award-number":["202209307001"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bbrc.2025.151344","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T16:05:05Z","timestamp":1737216305000},"page":"151344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Direct effects of antipsychotics on potassium channels"],"prefix":"10.1016","volume":"749","author":[{"given":"Wenwen","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo-Yeong","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5868-3797","authenticated-orcid":false,"given":"Won Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151344_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41569-020-00463-7","article-title":"Cardiovascular disease in patients with severe mental illness","volume":"18","author":"Nielsen","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrc.2025.151344_bib2","article-title":"Antipsychotic drug treatment for elderly people with late-onset schizophrenia","volume":"2012","author":"Essali","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YCO.0000000000000706","article-title":"Schizophrenia during pregnancy","volume":"34","author":"Dazzan","year":"2021","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib4","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1176\/appi.ajp.2008.08081180","article-title":"New findings on antipsychotic use in children and adolescents with schizophrenia spectrum disorders","volume":"165","author":"Ross","year":"2008","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114689","article-title":"Epigenetic age dysregulation in individuals with bipolar disorder and schizophrenia","volume":"315","author":"Jeremian","year":"2022","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbi.2016.12.010","article-title":"The microbiome, immunity, and schizophrenia and bipolar disorder","volume":"62","author":"Dickerson","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbrc.2025.151344_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121522","article-title":"Nicorandil reduces morphine withdrawal symptoms, potentiates morphine antinociception, and ameliorates liver fibrosis in rats","volume":"319","author":"Bedair","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1073858409341085","article-title":"Homeostatic regulation of neuronal excitability by K(+) channels in normal and diseased brains","volume":"16","author":"Misonou","year":"2010","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbrc.2025.151344_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tcm.2015.07.002","article-title":"Mechanisms contributing to myocardial potassium channel diversity, regulation and remodeling","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2025.151344_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/CIRCULATIONAHA.118.034731","article-title":"Polycystin-1 assembles with kv channels to govern cardiomyocyte repolarization and contractility","volume":"140","author":"Altamirano","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2025.151344_bib11","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1113\/JP272864","article-title":"Potassium channels in the heart: structure, function and regulation","volume":"595","author":"Grandi","year":"2017","journal-title":"J Physiol."},{"key":"10.1016\/j.bbrc.2025.151344_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105301","article-title":"Potassium channels in behavioral brain disorders. Molecular mechanisms and therapeutic potential: a narrative review","volume":"152","author":"Alam","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cbdd.12237","article-title":"Potassium channels: structures, diseases, and modulators","volume":"83","author":"Tian","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bbrc.2025.151344_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11154-010-9144-2","article-title":"Pancreatic beta-cell KATP channels: hypoglycaemia and hyperglycaemia","volume":"11","author":"Bennett","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bbrc.2025.151344_bib15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/ATVBAHA.112.300560","article-title":"Depolarization of mitochondria in endothelial cells promotes cerebral artery vasodilation by activation of nitric oxide synthase","volume":"33","author":"Katakam","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2025.151344_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910847","article-title":"Anti-inflammatory effect of licochalcone A via regulation of ORAI1 and K(+) channels in T-lymphocytes","volume":"22","author":"Phan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tips.2021.03.005","article-title":"Targeting of potassium channels in cardiac arrhythmias","volume":"42","author":"Burg","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib18","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2174\/1381612043383872","article-title":"Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?","volume":"10","author":"Pacher","year":"2004","journal-title":"Curr. Pharmaceut. Des."},{"issue":"Suppl B","key":"10.1016\/j.bbrc.2025.151344_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/eurheartj\/14.suppl_B.2","article-title":"Potassium channels as pharmacological targets in cardiovascular medicine","volume":"14","author":"Escande","year":"1993","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2025.151344_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.903156","article-title":"Antipsychotic drug development: from historical evidence to fresh perspectives","volume":"13","author":"Weston-Green","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib21","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00002018-200023030-00004","article-title":"Cardiovascular adverse effects of antipsychotic drugs","volume":"23","author":"Buckley","year":"2000","journal-title":"Drug Saf."},{"key":"10.1016\/j.bbrc.2025.151344_bib23","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","article-title":"Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death","volume":"158","author":"Glassman","year":"2001","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib24","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2174\/0929867043364351","article-title":"Torsadogenic cardiotoxicity of antipsychotic drugs: a structural feature, potentially involved in the interaction with cardiac HERG potassium channels","volume":"11","author":"Testai","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151344_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/hrt.2009.188367","article-title":"Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death","volume":"97","author":"van Noord","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.bbrc.2025.151344_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neulet.2006.11.018","article-title":"Risperidone reduces mRNA expression levels of Sulfonylurea Receptor 1 and TASK1 in PC12 cells","volume":"412","author":"Ota","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2025.151344_bib27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuropharm.2005.10.005","article-title":"The human Ca2+-activated K+ channel, Ik, can be blocked by the tricyclic antihistamine promethazine","volume":"50","author":"Wittekindt","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrc.2025.151344_bib28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0028-3908(01)00007-7","article-title":"Pharmacological characterisation of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines","volume":"40","author":"Terstappen","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrc.2025.151344_bib29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/brainsci13030414","article-title":"Application of antipsychotic drugs in mood disorders","volume":"13","author":"Rybakowski","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/ph14060514","article-title":"Therapeutic drug monitoring of second- and third-generation antipsychotic drugs-influence of smoking behavior and inflammation on pharmacokinetics","volume":"14","author":"Moschny","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2025.151344_bib31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1176\/appi.ajp.21101083","article-title":"Muscarinic acetylcholine receptor agonists as novel treatments for schizophrenia","volume":"179","author":"Paul","year":"2022","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151344_bib33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.tips.2008.03.009","article-title":"Antipsychotic drug action: antagonism, inverse agonism or partial agonism","volume":"29","author":"Strange","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105454","article-title":"An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs","volume":"155","author":"Chow","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib35","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.5694\/j.1326-5377.2003.tb05309.x","article-title":"Pharmacological approaches to the management of schizophrenia","volume":"178","author":"Lambert","year":"2003","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.bbrc.2025.151344_bib36","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1440-1819.2004.01230.x","article-title":"Differences of satisfaction with medication between patients with schizophrenia treated with typical antipsychotics and atypical antipsychotics","volume":"58","author":"Watanabe","year":"2004","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.bbrc.2025.151344_bib37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1517\/17425255.2011.562198","article-title":"Antipsychotic drug toxicology in children","volume":"7","author":"Caccia","year":"2011","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.bbrc.2025.151344_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2019.04.006","article-title":"Effects of cariprazine on hERG 1A and hERG 1A\/3.1 potassium channels","volume":"854","author":"Lee","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4196\/kjpp.2020.24.6.545","article-title":"Open channel block of Kv1.4 potassium channels by aripiprazole","volume":"24","author":"Park","year":"2020","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"key":"10.1016\/j.bbrc.2025.151344_bib40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11892-019-1220-8","article-title":"Association between antipsychotic medication use and diabetes","volume":"19","author":"Holt","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.bbrc.2025.151344_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0010-440X(99)90082-2","article-title":"A history of antipsychotic drug development","volume":"40","author":"Shen","year":"1999","journal-title":"Compr. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib42","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0024-3205(84)90607-6","article-title":"Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics","volume":"34","author":"Christensen","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib43","first-page":"CD009227","article-title":"Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia","volume":"2014","author":"Tardy","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/03602537908993895","article-title":"Penfluridol: a neuroleptic drug designed for long duration of action","volume":"9","author":"Migdalof","year":"1979","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00004583-200402000-00017","article-title":"Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial","volume":"43","author":"Gilbert","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.bbrc.2025.151344_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pediatrneurol.2009.04.002","article-title":"Body mass index changes and chronic neuroleptic drug treatment for Tourette syndrome","volume":"41","author":"Degrauw","year":"2009","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bbrc.2025.151344_bib47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1176\/ajp.156.2.294","article-title":"Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response","volume":"156","author":"Breier","year":"1999","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2025.151344_bib49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1176\/appi.ajp.159.2.180","article-title":"Amisulpride, an unusual \"atypical\" antipsychotic: a meta-analysis of randomized controlled trials","volume":"159","author":"Leucht","year":"2002","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108236","article-title":"Clozapine's multiple cellular mechanisms: what do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia","volume":"236","author":"de Bartolomeis","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151344_bib51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3956(96)00039-8","article-title":"Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action","volume":"31","author":"Sanyal","year":"1997","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib52","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","article-title":"Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia","volume":"156","author":"Kapur","year":"1999","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.711940","article-title":"Genetic polymorphisms associated with the pharmacokinetics, pharmacodynamics and adverse effects of olanzapine, aripiprazole and risperidone","volume":"12","author":"Soria-Chacartegui","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neubiorev.2017.12.012","article-title":"The use of quetiapine in the treatment of major depressive disorder: evidence from clinical and experimental studies","volume":"86","author":"Ignacio","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2017.11.029","article-title":"Effects of norquetiapine, the active metabolite of quetiapine, on cloned hERG potassium channels","volume":"664","author":"Lee","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2025.151344_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/11208320-000000000-00000","article-title":"Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder","volume":"72","author":"Dhillon","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2025.151344_bib57","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/138161210790361461","article-title":"Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?","volume":"16","author":"Mailman","year":"2010","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.bbrc.2025.151344_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/YIC.0000000000000035","article-title":"Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia","volume":"29","author":"Poyurovsky","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib59","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00228-018-2498-1","article-title":"Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews","volume":"74","author":"Ribeiro","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.euroneuro.2015.01.014","article-title":"Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors","volume":"25","author":"Ishima","year":"2015","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.bbrc.2025.151344_bib61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40265-019-1052-5","article-title":"Brexpiprazole: a review in schizophrenia","volume":"79","author":"Frampton","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2025.151344_bib62","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s40265-015-0494-7","article-title":"Cariprazine: first global approval","volume":"75","author":"McCormack","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2025.151344_bib63","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3390\/molecules23082087","article-title":"Current concepts and treatments of schizophrenia","volume":"23","author":"Stepnicki","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2025.151344_bib64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13046-020-1534-z","article-title":"Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps","volume":"39","author":"Abbruzzese","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib65","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/bmj.1.5085.1452","article-title":"Clinical trial of acepromazine maleate in chronic schizophrenia","volume":"1","author":"Collard","year":"1958","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bbrc.2025.151344_bib66","series-title":"Fluphenazine, StatPearls","author":"Siragusa","year":"2024"},{"key":"10.1016\/j.bbrc.2025.151344_bib67","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0024-3205(88)90519-X","article-title":"Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites","volume":"43","author":"Hals","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2006.06.009","article-title":"Blockade of HERG human K+ channel and IKr of Guinea pig cardiomyocytes by prochlorperazine","volume":"544","author":"Kim","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib69","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0014-2999(78)90297-2","article-title":"Antagonism of central histamine H1 receptors by antipsychotic drugs","volume":"52","author":"Hill","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib70","article-title":"Trifluoperazine for schizophrenia","volume":"2004","author":"Marques","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib71","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3928\/02793695-20151223-01","article-title":"Trifluoperazine: a sprightly old drug","volume":"54","author":"Howland","year":"2016","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"key":"10.1016\/j.bbrc.2025.151344_bib72","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pds.3346","article-title":"Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort","volume":"21","author":"Purhonen","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.bbrc.2025.151344_bib73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10401230591002048","article-title":"The haloperidol story","volume":"17","author":"Granger","year":"2005","journal-title":"Ann. Clin. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib74","first-page":"275","article-title":"[Clinical testing of a new long-term neuroleptic (Fluspirilene) with special reference to the neuroleptic threshold]","volume":"39","author":"Haase","year":"1968","journal-title":"Nervenarzt"},{"key":"10.1016\/j.bbrc.2025.151344_bib75","first-page":"421","article-title":"Pimozide: use in Tourette's syndrome","volume":"19","author":"Colvin","year":"1985","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.bbrc.2025.151344_bib76","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002","article-title":"Differential inhibition of T-type calcium channels by neuroleptics","volume":"22","author":"Santi","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2025.151344_bib77","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s004240000322","article-title":"ATP-sensitive potassium channels in freshly dissociated adult rat striatal neurons: activation by metabolic inhibitors and the dopaminergic receptor agonist quinpirole","volume":"440","author":"Sun","year":"2000","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.bbrc.2025.151344_bib78","first-page":"29","article-title":"A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes","volume":"21","author":"Singh","year":"1996","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbrc.2025.151344_bib79","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd3027","article-title":"Asenapine","volume":"8","author":"Meltzer","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.151344_bib80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0957154X07070335","article-title":"The history of clozapine and its emergence in the US market: a review and analysis","volume":"18","author":"Crilly","year":"2007","journal-title":"Hist. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib81","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/jat.3986","article-title":"Inhibition of voltage-dependent K(+) channels by iloperidone in coronary arterial smooth muscle cells","volume":"40","author":"An","year":"2020","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.bbrc.2025.151344_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176005","article-title":"Lurasidone blocks the voltage-gated potassium channels of coronary arterial smooth muscle cells","volume":"957","author":"Zhuang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib83","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/ajp.155.7.921","article-title":"5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation","volume":"155","author":"Kapur","year":"1998","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib84","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1742-1241.2007.01321.x","article-title":"Paliperidone: quo vadis?","volume":"61","author":"Citrome","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bbrc.2025.151344_bib85","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/nedt.2007.3.2.219","article-title":"Quetiapine in the treatment of schizophrenia and related disorders","volume":"3","author":"Riedel","year":"2007","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.bbrc.2025.151344_bib86","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/1933719110372420","article-title":"Risperidone inhibits contractions induced by serotonin and histamine and reduces K+ currents in smooth muscle of human umbilical artery","volume":"17","author":"Iveli","year":"2010","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib87","article-title":"Sertindole for schizophrenia","volume":"2005","author":"Lewis","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/JCNSD.S4138","article-title":"Ziprasidone hydrocloride: what role in the management of schizophrenia?","volume":"3","author":"Mattei","year":"2011","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.bbrc.2025.151344_bib89","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/13543784.16.6.771","article-title":"Aripiprazole acts as a selective dopamine D2 receptor partial agonist","volume":"16","author":"Wood","year":"2007","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.bbrc.2025.151344_bib90","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2174\/1570159X15666170413115754","article-title":"Aripiprazole, A drug that displays partial agonism and functional selectivity","volume":"15","author":"Tuplin","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib91","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/jpet.114.213793","article-title":"Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator","volume":"350","author":"Maeda","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.bbrc.2025.151344_bib92","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1073\/pnas.97.14.7673","article-title":"Schizophrenia: more dopamine, more D2 receptors","volume":"97","author":"Seeman","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.bbrc.2025.151344_bib93","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1515\/hsz-2019-0153","article-title":"How RCK domains regulate gating of K+ channels","volume":"400","author":"Schrecker","year":"2019","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.151344_bib94","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0163-7258(02)00201-2","article-title":"K(+) channels as therapeutic drug targets","volume":"94","author":"Wickenden","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151344_bib95","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s00415-012-6727-8","article-title":"Potassium channels: a review of broadening therapeutic possibilities for neurological diseases","volume":"260","author":"Maljevic","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbrc.2025.151344_bib96","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1007\/s00018-015-1948-5","article-title":"Structure of potassium channels","volume":"72","author":"Kuang","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib97","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1517\/13543776.2010.513384","article-title":"Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy","volume":"20","author":"Castle","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bbrc.2025.151344_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.611853","article-title":"Voltage-gated potassium channels as regulators of cell death","volume":"8","author":"Bachmann","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2025.151344_bib99","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12975-013-0297-7","article-title":"Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration","volume":"5","author":"Shah","year":"2014","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.bbrc.2025.151344_bib100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/cphy.c160011","article-title":"Smooth muscle ion channels and regulation of vascular tone in resistance arteries and arterioles","volume":"7","author":"Tykocki","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbrc.2025.151344_bib101","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s41467-022-29745-z","article-title":"Pyridine nucleotide redox potential in coronary smooth muscle couples myocardial blood flow to cardiac metabolism","volume":"13","author":"Dwenger","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cbi.2019.03.023","article-title":"Biochemical and physiological properties of K(+) channel-associated AKR6A (Kvbeta) proteins","volume":"305","author":"Raph","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbrc.2025.151344_bib103","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s42003-023-05021-8","article-title":"Ancient medicinal plant rosemary contains a highly efficacious and isoform-selective KCNQ potassium channel opener","volume":"6","author":"Manville","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2025.151344_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114673","article-title":"Potassium channels, tumorigenesis and targeted drugs","volume":"162","author":"Xia","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2025.151344_bib105","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3390\/cells11142230","article-title":"Diversification of potassium currents in excitable cells via kvbeta proteins","volume":"11","author":"Dwenger","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2025.151344_bib106","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2010.10.066","article-title":"Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo","volume":"651","author":"Jang","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib107","doi-asserted-by":"crossref","first-page":"613","DOI":"10.21147\/j.issn.1000-9604.2018.06.06","article-title":"Voltage-gated K(+) channels promote BT-474 breast cancer cell migration","volume":"30","author":"Chow","year":"2018","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2015.09.059","article-title":"KCNE1 and KCNE3: the yin and yang of voltage-gated K(+) channel regulation","volume":"576","author":"Abbott","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2025.151344_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106684","article-title":"Sigma-1 receptor modulation fine-tunes K(V)1.5 channels and impacts pulmonary vascular function","volume":"189","author":"Vera-Zambrano","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106765","article-title":"Chinese herbal medicine for the treatment of cardiovascular diseases horizontal line Targeting cardiac ion channels","volume":"192","author":"Yan","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113437","article-title":"The potassium channel Kv4.2 regulates dendritic spine morphology, electroencephalographic characteristics and seizure susceptibility in mice","volume":"334","author":"Tiwari","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2025.151344_bib112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1476-5381.2012.02133.x","article-title":"One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders","volume":"168","author":"Jepps","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib113","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ng.3153","article-title":"Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy","volume":"47","author":"Simons","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2025.151344_bib114","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.tips.2017.06.004","article-title":"Towards a structural view of drug binding to hERG K(+) channels","volume":"38","author":"Vandenberg","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.57.4.9","article-title":"International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels","volume":"57","author":"Wei","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib116","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2174\/1570159X21666221208091805","article-title":"K(Ca)-Related neurological disorders: phenotypic spectrum and therapeutic indications","volume":"21","author":"Zahra","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib117","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1152\/physiol.00032.2008","article-title":"Modulation of BKCa channel gating by endogenous signaling molecules","volume":"24","author":"Hou","year":"2009","journal-title":"Physiology"},{"key":"10.1016\/j.bbrc.2025.151344_bib118","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1517\/14728222.2010.500616","article-title":"Calcium-activated potassium channels - a therapeutic target for modulating nitric oxide in cardiovascular disease?","volume":"14","author":"Dalsgaard","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbrc.2025.151344_bib119","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3760\/cma.j.issn.0366-6999.20132503","article-title":"Role of BK(Ca) channels in diabetic vascular complications","volume":"127","author":"Qian","year":"2014","journal-title":"Chin Med J (Engl)."},{"key":"10.1016\/j.bbrc.2025.151344_bib120","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/antiox9080760","article-title":"BK(Ca) channels as targets for cardioprotection","volume":"9","author":"Szteyn","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2025.151344_bib121","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/21691401.2014.930746","article-title":"Inhibition of BKCa channel currents in vascular smooth muscle cells contributes to HBOC-induced vasoconstriction","volume":"44","author":"Zhang","year":"2016","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.bbrc.2025.151344_bib122","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/CIRCRESAHA.114.302168","article-title":"AKAP150 contributes to enhanced vascular tone by facilitating large-conductance Ca2+-activated K+ channel remodeling in hyperglycemia and diabetes mellitus","volume":"114","author":"Nystoriak","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib123","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2015.07.021","article-title":"ER stress mediates homocysteine-induced endothelial dysfunction: modulation of IKCa and SKCa channels","volume":"242","author":"Wang","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2025.151344_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.590534","article-title":"Small and intermediate calcium activated potassium channels in the heart: role and strategies in the treatment of cardiovascular diseases","volume":"11","author":"Weisbrod","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2025.151344_bib125","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/pr.57.4.11","article-title":"International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels","volume":"57","author":"Kubo","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib126","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00021.2009","article-title":"Inwardly rectifying potassium channels: their structure, function, and physiological roles","volume":"90","author":"Hibino","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib127","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neures.2020.07.006","article-title":"Clozapine, nimodipine and endosulfan differentially suppress behavioral defects caused by gain-of-function mutations in a two-pore domain K(+) channel (UNC-58)","volume":"170","author":"Kasap","year":"2021","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1515\/acph-2016-0006","article-title":"The therapeutic agents that target ATP-sensitive potassium channels","volume":"66","author":"Rubaiy","year":"2016","journal-title":"Acta Pharm."},{"key":"10.1016\/j.bbrc.2025.151344_bib129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1582-4934.2006.tb00289.x","article-title":"Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions","volume":"10","author":"Butt","year":"2006","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2025.151344_bib130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbrc.2016.03.100","article-title":"Non-basic amino acids in the ROMK1 channels via an appropriate distance modulate PIP2 regulated pHi-gating","volume":"473","author":"Lee","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/membranes12111119","article-title":"The relevance of GIRK channels in heart function","volume":"12","author":"Campos-Rios","year":"2022","journal-title":"Membranes"},{"key":"10.1016\/j.bbrc.2025.151344_bib132","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1161\/CIRCRESAHA.116.310112","article-title":"A mutation in the G-protein gene GNB2 causes familial sinus node and atrioventricular conduction dysfunction","volume":"120","author":"Stallmeyer","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib133","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1399-543X.2005.00109.x","article-title":"From congenital hyperinsulinism to diabetes mellitus: the role of pancreatic beta-cell KATP channels","volume":"6","author":"Hussain","year":"2005","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.bbrc.2025.151344_bib134","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-030920-111536","article-title":"Two-pore domain potassium channels as drug targets: anesthesia and beyond","volume":"61","author":"Mathie","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbrc.2025.151344_bib135","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00754-2017","article-title":"TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications","volume":"50","author":"Olschewski","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2025.151344_bib136","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pharmthera.2018.10.003","article-title":"Fighting against depression with TREK-1 blockers: past and future. A focus on spadin","volume":"194","author":"Djillani","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151344_bib137","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2016.04.006","article-title":"The two-pore domain potassium channel, TWIK-1, has a role in the regulation of heart rate and atrial size","volume":"97","author":"Christensen","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2025.151344_bib138","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/s41467-017-02172-1","article-title":"Input-dependent regulation of excitability controls dendritic maturation in somatosensory thalamocortical neurons","volume":"8","author":"Frangeul","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib139","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1038\/s41467-022-31285-5","article-title":"Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators","volume":"13","author":"Selvakumar","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fnmol.2018.00253","article-title":"A-type K(V) channels in dorsal root ganglion neurons: diversity, function, and dysfunction","volume":"11","author":"Zemel","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbrc.2025.151344_bib141","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1152\/physrev.00022.2013","article-title":"Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia","volume":"94","author":"Schmitt","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib142","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1084\/jem.20020381","article-title":"Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation","volume":"196","author":"Liu","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2025.151344_bib143","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/brain\/awl084","article-title":"Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations","volume":"129","author":"Kleopa","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2025.151344_bib144","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1074\/jbc.273.10.5851","article-title":"Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7","volume":"273","author":"Kalman","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.151344_bib145","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1097\/01.ASN.0000036866.37886.C5","article-title":"Expression of KCNA10, a voltage-gated K channel, in glomerular endothelium and at the apical membrane of the renal proximal tubule","volume":"13","author":"Yao","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2025.151344_bib146","article-title":"Molecular mechanism responsible for sex differences in electrical activity of mouse pancreatic beta cells","volume":"9","author":"Jacobo-Piqueras","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2025.151344_bib147","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-023-06582-8","article-title":"Inactivation of the Kv2.1 channel through electromechanical coupling","volume":"622","author":"Fernandez-Marino","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.151344_bib148","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.RES.84.3.352","article-title":"Angiotensin II type 1 receptor-mediated inhibition of K+ channel subunit kv2.2 in brain stem and hypothalamic neurons","volume":"84","author":"Gelband","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib149","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1152\/physrev.00002.2017","article-title":"Kv3 channels: enablers of rapid firing, neurotransmitter release, and neuronal endurance","volume":"97","author":"Kaczmarek","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2025.151344_bib150","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1038\/s41467-024-46813-8","article-title":"The binding and mechanism of a positive allosteric modulator of Kv3 channels","volume":"15","author":"Liang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib151","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0896-6273(04)00045-5","article-title":"Structural insights into the functional interaction of KChIP1 with Shal-type K(+) channels","volume":"41","author":"Zhou","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2025.151344_bib152","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/ejp.2038","article-title":"K(+) channel Kv4.1 is expressed in the nociceptors\/secondary nociceptive neurons and participates in pain regulation","volume":"26","author":"Chiu","year":"2022","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.bbrc.2025.151344_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029134","article-title":"Kv4.2 mediates histamine modulation of preoptic neuron activity and body temperature","volume":"6","author":"Sethi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.151344_bib154","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1073\/pnas.1916166117","article-title":"Determining the correct stoichiometry of Kv2.1\/Kv6.4 heterotetramers, functional in multiple stoichiometrical configurations","volume":"117","author":"Moller","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbrc.2025.151344_bib155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1085\/jgp.201511507","article-title":"Kv5, Kv6, Kv8, and Kv9 subunits: No simple silent bystanders","volume":"147","author":"Bocksteins","year":"2016","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.bbrc.2025.151344_bib156","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-pharmtox-010919-023645","article-title":"Hormonal signaling actions on Kv7.1 (KCNQ1) channels","volume":"61","author":"Thompson","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbrc.2025.151344_bib157","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1073\/pnas.1800235115","article-title":"Structural basis and energy landscape for the Ca(2+) gating and calmodulation of the Kv7.2 K(+) channel","volume":"115","author":"Bernardo-Seisdedos","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.bbrc.2025.151344_bib158","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1038\/ncomms7254","article-title":"KCNQ5 K(+) channels control hippocampal synaptic inhibition and fast network oscillations","volume":"6","author":"Fidzinski","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib159","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/CIRCULATIONAHA.111.032136","article-title":"Downregulation of Kv7.4 channel activity in primary and secondary hypertension","volume":"124","author":"Jepps","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2025.151344_bib160","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1073\/pnas.1418605112","article-title":"G-protein betagamma subunits are positive regulators of Kv7.4 and native vascular Kv7 channel activity","volume":"112","author":"Stott","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbrc.2025.151344_bib161","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1006\/bbrc.1998.9072","article-title":"Cloning and tissue distribution of two new potassium channel alpha-subunits from rat brain","volume":"248","author":"Stocker","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib162","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1176\/appi.ajp.2013.13040468","article-title":"Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia","volume":"171","author":"Georgiev","year":"2014","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbrc.2025.151344_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810533","article-title":"The hEag1 K(+) channel inhibitor astemizole stimulates Ca(2+) deposition in SaOS-2 and MG-63 osteosarcoma cultures","volume":"23","author":"Meszaros","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114089","article-title":"Procyanidin B1, a novel and specific inhibitor of Kv10.1 channel, suppresses the evolution of hepatoma","volume":"178","author":"Na","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib165","doi-asserted-by":"crossref","first-page":"16586","DOI":"10.1523\/JNEUROSCI.2307-13.2013","article-title":"Multistate structural modeling and voltage-clamp analysis of epilepsy\/autism mutation Kv10.2-R327H demonstrate the role of this residue in stabilizing the channel closed state","volume":"33","author":"Yang","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2025.151344_bib166","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13023-022-02499-z","article-title":"A novel loss-of-function mutation of the voltage-gated potassium channel Kv10.2 involved in epilepsy and autism","volume":"17","author":"Galan-Vidal","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbrc.2025.151344_bib167","article-title":"HERG channel and cancer: a mechanistic review of carcinogenic processes and therapeutic potential","volume":"1873","author":"He","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bbrc.2025.151344_bib168","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00424-009-0651-5","article-title":"Functional properties of human neuronal Kv11 channels","volume":"458","author":"Einarsen","year":"2009","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.bbrc.2025.151344_bib169","doi-asserted-by":"crossref","first-page":"13277","DOI":"10.1074\/jbc.RA120.014150","article-title":"Discovery of a heme-binding domain in a neuronal voltage-gated potassium channel","volume":"295","author":"Burton","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.151344_bib170","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1085\/jgp.201210938","article-title":"External pH modulates EAG superfamily K+ channels through EAG-specific acidic residues in the voltage sensor","volume":"141","author":"Kazmierczak","year":"2013","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.bbrc.2025.151344_bib171","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nn.2610","article-title":"Deletion of the potassium channel Kv12.2 causes hippocampal hyperexcitability and epilepsy","volume":"13","author":"Zhang","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2025.151344_bib172","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/CIRCULATIONAHA.121.058607","article-title":"Novel smooth muscle Ca(2+)-signaling nanodomains in blood pressure regulation","volume":"146","author":"Chen","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2025.151344_bib173","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physiol.00040.2005","article-title":"Calcium-activated potassium channels and the regulation of vascular tone","volume":"21","author":"Ledoux","year":"2006","journal-title":"Physiology"},{"key":"10.1016\/j.bbrc.2025.151344_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151208","article-title":"Metabolic regulation and dysregulation of endothelial small conductance calcium activated potassium channels","volume":"101","author":"Kant","year":"2022","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.151344_bib175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303238120","article-title":"Vasodilators mobilize SK3 channels in endothelial cells to produce arterial relaxation","volume":"120","author":"Peixoto-Neves","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbrc.2025.151344_bib176","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311205","article-title":"SLO3: a conserved regulator of sperm membrane potential","volume":"24","author":"Lyon","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib177","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1152\/physiol.00044.2004","article-title":"The protein tyrosine kinase-dependent pathway mediates the effect of K intake on renal K secretion","volume":"20","author":"Lin","year":"2005","journal-title":"Physiology"},{"key":"10.1016\/j.bbrc.2025.151344_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102628","article-title":"Kir4.1 dysfunction in the pathophysiology of depression: a systematic review","volume":"10","author":"Della Vecchia","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2025.151344_bib179","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4161\/19336950.2014.970448","article-title":"Kir4.1-mediated spatial buffering of K(+): experimental challenges in determination of its temporal and quantitative contribution to K(+) clearance in the brain","author":"Larsen","year":"2014","journal-title":"Channels"},{"key":"10.1016\/j.bbrc.2025.151344_bib180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/HYPERTENSIONAHA.123.21389","article-title":"Role of angiotensin II type 1a receptor (AT1aR) of renal tubules in regulating inwardly rectifying potassium channels 4.2 (Kir4.2), Kir4.1, and epithelial Na(+) channel (ENaC)","volume":"81","author":"Duan","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2025.151344_bib181","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.kint.2019.10.029","article-title":"Potassium channels in control of renal function","volume":"97","author":"Imenez Silva","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2025.151344_bib182","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143251","article-title":"Kcnj16 knockout produces audiogenic seizures in the Dahl salt-sensitive rat","volume":"6","author":"Manis","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2025.151344_bib183","doi-asserted-by":"crossref","first-page":"C1178","DOI":"10.1152\/ajpcell.00597.2023","article-title":"Normal vision and development in mice with low functional expression of Kir7.1 in heterozygosis for a blindness-producing mutation inactivating the channel","volume":"326","author":"Vera","year":"2024","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bbrc.2025.151344_bib184","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.15252\/emmm.201403944","article-title":"The inwardly rectifying K+ channel KIR7.1 controls uterine excitability throughout pregnancy","volume":"6","author":"McCloskey","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrc.2025.151344_bib185","doi-asserted-by":"crossref","first-page":"C694","DOI":"10.1152\/ajpcell.00335.2022","article-title":"The unique structural characteristics of the Kir 7.1 inward rectifier potassium channel: a novel player in energy homeostasis control","volume":"324","author":"Hernandez","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bbrc.2025.151344_bib186","doi-asserted-by":"crossref","first-page":"eabq8489","DOI":"10.1126\/sciadv.abq8489","article-title":"Cryo-electron microscopy unveils unique structural features of the human Kir2.1 channel","volume":"8","author":"Fernandes","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2025.151344_bib187","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.cmet.2022.08.016","article-title":"Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1","volume":"34","author":"Chen","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrc.2025.151344_bib188","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1038\/ncomms5676","article-title":"Carbon monoxide inhibits inward rectifier potassium channels in cardiomyocytes","volume":"5","author":"Liang","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib189","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005800","article-title":"Inward rectifier potassium channels (Kir2.x) and caveolin-3 domain-specific interaction: implications for purkinje cell-dependent ventricular arrhythmias","volume":"11","author":"Vaidyanathan","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.bbrc.2025.151344_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108741","article-title":"Hypoxic and osmotic expression of Kir2.1 potassium channels in retinal pigment epithelial cells: contribution to vascular endothelial growth factor expression","volume":"211","author":"Klose","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib191","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1161\/CIRCULATIONAHA.118.036761","article-title":"Mutant KCNJ3 and KCNJ5 potassium channels as novel molecular targets in bradyarrhythmias and atrial fibrillation","volume":"139","author":"Yamada","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2025.151344_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107808","article-title":"Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system","volume":"223","author":"Jeremic","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151344_bib193","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/ejn.12526","article-title":"Distinct axo-somato-dendritic distributions of three potassium channels in CA1 hippocampal pyramidal cells","volume":"39","author":"Kirizs","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbrc.2025.151344_bib194","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1021\/acs.jpcb.3c06739","article-title":"Insights into activation dynamics and functional sites of inwardly rectifying potassium channel Kir3.2 by an elastic network model combined with perturbation methods","volume":"128","author":"Zhao","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbrc.2025.151344_bib195","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1073\/pnas.1416146112","article-title":"GIRK3 gates activation of the mesolimbic dopaminergic pathway by ethanol","volume":"112","author":"Herman","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.bbrc.2025.151344_bib196","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109441118","article-title":"Vascular K(ATP) channel structural dynamics reveal regulatory mechanism by Mg-nucleotides","volume":"118","author":"Sung","year":"2021","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.bbrc.2025.151344_bib197","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbi.2021.04.003","article-title":"Astrocytic Kir6.1 deletion aggravates neurodegeneration in the lipopolysaccharide-induced mouse model of Parkinson's disease via astrocyte-neuron cross talk through complement C3-C3R signaling","volume":"95","author":"Chen","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbrc.2025.151344_bib198","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41467-021-22651-w","article-title":"CRISPR-based genome editing in primary human pancreatic islet cells","volume":"12","author":"Bevacqua","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112447","article-title":"Eugenosedin-A improves obesity-related hyperglycemia by regulating ATP-sensitive K(+) channels and insulin secretion in pancreatic beta cells","volume":"145","author":"Lin","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2025.151344_bib200","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1038\/ncomms5377","article-title":"A hydrophobic barrier deep within the inner pore of the TWIK-1 K2P potassium channel","volume":"5","author":"Aryal","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib201","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1152\/ajpregu.00126.2013","article-title":"Endothelium-dependent relaxations in the aorta from K(2p)6.1 knockout mice","volume":"305","author":"Lloyd","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbrc.2025.151344_bib202","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2250-8","article-title":"A lower X-gate in TASK channels traps inhibitors within the vestibule","volume":"582","author":"Rodstrom","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.151344_bib203","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jce.13805","article-title":"K(2p) 3.1 protein is expressed as a transmural gradient across the rat left ventricular free wall","volume":"30","author":"Jones","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.bbrc.2025.151344_bib204","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13361","article-title":"Effects of the ventilatory stimulant, doxapram on human TASK-3 (KCNK9, K2P9.1) channels and TASK-1 (KCNK3, K2P3.1) channels","volume":"228","author":"Cunningham","year":"2020","journal-title":"Acta Physiol."},{"key":"10.1016\/j.bbrc.2025.151344_bib205","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.3390\/ijms20205193","article-title":"N-glycosylation of TREK-1\/hK(2P)2.1 two-pore-domain potassium (K(2P)) channels","volume":"20","author":"Wiedmann","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib206","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1073\/pnas.1218950110","article-title":"Domain-swapped chain connectivity and gated membrane access in a Fab-mediated crystal of the human TRAAK K+ channel","volume":"110","author":"Brohawn","year":"2013","journal-title":"Proc Natl Acad Sci. U S A"},{"key":"10.1016\/j.bbrc.2025.151344_bib207","doi-asserted-by":"crossref","first-page":"C649","DOI":"10.1152\/ajpcell.00047.2006","article-title":"Mechanism of inhibition of TREK-2 (K2P10.1) by the Gq-coupled M3 muscarinic receptor","volume":"291","author":"Kang","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bbrc.2025.151344_bib208","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00424-013-1314-0","article-title":"G protein modulation of K2P potassium channel TASK-2 : a role of basic residues in the C terminus domain","volume":"465","author":"Anazco","year":"2013","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.bbrc.2025.151344_bib209","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fphys.2013.00198","article-title":"TASK-2: a K2P K(+) channel with complex regulation and diverse physiological functions","volume":"4","author":"Cid","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2025.151344_bib210","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00210-018-1535-z","article-title":"Cardiovascular pharmacology of K(2P)17.1 (TASK-4, TALK-2) two-pore-domain K(+) channels","volume":"391","author":"Staudacher","year":"2018","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib211","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuron.2017.12.002","article-title":"Microglial ramification, surveillance, and interleukin-1beta release are regulated by the two-pore domain K(+) channel THIK-1","volume":"97","author":"Madry","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2025.151344_bib212","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4062\/biomolther.2016.038","article-title":"Enhanced expression of TREK-1 is related with chronic constriction injury of neuropathic pain mouse model in dorsal root ganglion","volume":"24","author":"Han","year":"2016","journal-title":"Biomol Ther (Seoul)."},{"key":"10.1016\/j.bbrc.2025.151344_bib213","doi-asserted-by":"crossref","first-page":"12810","DOI":"10.1523\/JNEUROSCI.1237-13.2013","article-title":"Functional analysis of a migraine-associated TRESK K+ channel mutation","volume":"33","author":"Liu","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2025.151344_bib214","article-title":"Identification of key potassium channel genes of temporal lobe epilepsy by bioinformatics analyses and experimental verification","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbrc.2025.151344_bib215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/adt.2018.882","article-title":"Electrophysiological and pharmacological characterization of human inwardly rectifying K(ir)2.1 channels on an automated patch-clamp platform","volume":"17","author":"Sanson","year":"2019","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.bbrc.2025.151344_bib216","doi-asserted-by":"crossref","first-page":"E6696","DOI":"10.1073\/pnas.1603101113","article-title":"Allosteric binding site in a Cys-loop receptor ligand-binding domain unveiled in the crystal structure of ELIC in complex with chlorpromazine","volume":"113","author":"Nys","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbrc.2025.151344_bib217","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1111\/j.1476-5381.1995.tb17214.x","article-title":"Characterization of inhibition by haloperidol and chlorpromazine of a voltage-activated K+ current in rat phaeochromocytoma cells","volume":"116","author":"Nakazawa","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib218","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1074\/jbc.RA119.012377","article-title":"Chlorpromazine binding to the PAS domains uncovers the effect of ligand modulation on EAG channel activity","volume":"295","author":"Wang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.151344_bib219","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1081\/DCT-200064482","article-title":"The phenothiazine drugs inhibit hERG potassium channels","volume":"28","author":"Kim","year":"2005","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2025.151344_bib220","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0705283","article-title":"The antipsychotic drug chlorpromazine inhibits HERG potassium channels","volume":"139","author":"Thomas","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib221","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00401-5","article-title":"Block of rat brain recombinant SK channels by tricyclic antidepressants and related compounds","volume":"401","author":"Dreixler","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib222","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(91)90569-C","article-title":"Chlorpromazine and related phenothiazines inhibit the ATP-sensitive K+ channel","volume":"198","author":"Muller","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib223","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064471","article-title":"Modulation of TRESK background K+ channel by membrane stretch","volume":"8","author":"Callejo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.151344_bib224","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.phrs.2009.05.008","article-title":"H(1) antihistamine drug promethazine directly blocks hERG K(+) channel","volume":"60","author":"Jo","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib225","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbrc.2013.11.115","article-title":"The calmodulin inhibitor and antipsychotic drug trifluoperazine inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells","volume":"443","author":"Hong","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib226","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0006-2952(02)01561-7","article-title":"The voltage- and time-dependent blocking effect of trifluoperazine on T lymphocyte Kv1.3 channels","volume":"65","author":"Teisseyre","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib227","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bbrc.2006.10.039","article-title":"hERG K+ channel blockade by the antipsychotic drug thioridazine: an obligatory role for the S6 helix residue F656","volume":"351","author":"Milnes","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib228","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/bph.12575","article-title":"Allosteric effects of erythromycin pretreatment on thioridazine block of hERG potassium channels","volume":"171","author":"Crumb","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib229","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nn.4088","article-title":"EAG2 potassium channel with evolutionarily conserved function as a brain tumor target","volume":"18","author":"Huang","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2025.151344_bib230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0026-895X(25)13146-5","article-title":"Phenothiazines and haloperidol block Ca-activated K channels in rat forebrain synaptosomes","volume":"33","author":"Benishin","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib231","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4196\/kjpp.2017.21.1.75","article-title":"Acepromazine inhibits hERG potassium ion channels expressed in human embryonic kidney 293 cells","volume":"21","author":"Joo","year":"2017","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"key":"10.1016\/j.bbrc.2025.151344_bib232","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.rvsc.2019.01.009","article-title":"Compounds commonly used in equine medicine inhibits the voltage-gated potassium channel K(v)11.1","volume":"123","author":"Calloe","year":"2019","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.bbrc.2025.151344_bib233","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.06.043","article-title":"Effects of haloperidol on Kv4.3 potassium channels","volume":"740","author":"Lee","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib234","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.bjp.0700989","article-title":"The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes","volume":"120","author":"Suessbrich","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-2952(01)00611-6","article-title":"Testosterone-mediated modulation of HERG blockade by proarrhythmic agents","volume":"62","author":"Shuba","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib236","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/sj.bjp.0706017","article-title":"Inhibition of ATP-sensitive potassium channels by haloperidol","volume":"143","author":"Yang","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib237","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(00)00123-0","article-title":"High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide","volume":"392","author":"Kang","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib238","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/bbrc.2001.5434","article-title":"The antipsychotic drugs sertindole and pimozide block erg3, a human brain K(+) channel","volume":"286","author":"Kang","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib239","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0169-328X(03)00175-X","article-title":"Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels","volume":"115","author":"Zhang","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.bbrc.2025.151344_bib240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/01480545.2021.2021932","article-title":"The inhibitory effects of pimozide, an antipsychotic drug, on voltage-gated K(+) channels in rabbit coronary arterial smooth muscle cells","volume":"46","author":"Seo","year":"2023","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2025.151344_bib241","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/biomedicines11020488","article-title":"Pimozide increases a delayed rectifier K(+) conductance in chicken embryo vestibular hair cells","volume":"11","author":"Giunta","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2025.151344_bib242","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0006-8993(97)00315-6","article-title":"Stable expression and characterization of the human brain potassium channel Kv2.1: blockade by antipsychotic agents","volume":"761","author":"Wible","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2025.151344_bib243","doi-asserted-by":"crossref","first-page":"49186","DOI":"10.1074\/jbc.M207233200","article-title":"An ACTH- and ATP-regulated background K+ channel in adrenocortical cells is TREK-1","volume":"277","author":"Enyeart","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.151344_bib244","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.neuropharm.2006.06.003","article-title":"Pharmacological activation and inhibition of Slack (Slo2.2) channels","volume":"51","author":"Yang","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrc.2025.151344_bib245","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/jpet.111.184622","article-title":"The antipsychotic drug loxapine is an opener of the sodium-activated potassium channel slack (Slo2.2)","volume":"340","author":"Biton","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.bbrc.2025.151344_bib246","first-page":"803","article-title":"Asenapine review, part II: clinical efficacy, safety and tolerability","volume":"13","author":"Citrome","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.bbrc.2025.151344_bib247","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175318","article-title":"Asenapine, an atypical antipsychotic, blocks voltage-gated potassium channels in rabbit coronary artery smooth muscle cells","volume":"934","author":"Seo","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib248","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4196\/kjpp.2022.26.4.277","article-title":"Inhibitory effects of the atypical antipsychotic, clozapine, on voltage-dependent K(+) channels in rabbit coronary arterial smooth muscle cells","volume":"26","author":"Kang","year":"2022","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"key":"10.1016\/j.bbrc.2025.151344_bib249","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00210-022-02314-3","article-title":"The atypic antipsychotic clozapine inhibits multiple cardiac ion channels","volume":"396","author":"Le Marois","year":"2023","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib250","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/sj.bjp.0706744","article-title":"Blockade of HERG human K+ channels and IKr of Guinea-pig cardiomyocytes by the antipsychotic drug clozapine","volume":"148","author":"Lee","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib251","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.bjp.0701621","article-title":"Effects of clozapine on the delta- and kappa-opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes","volume":"123","author":"Kobayashi","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib252","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/WNR.0000000000001724","article-title":"Effects of iloperidone on hERG 1A\/3.1 heterotetrameric channels","volume":"32","author":"Lee","year":"2021","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbrc.2025.151344_bib253","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s43440-021-00299-z","article-title":"Atypical antipsychotic olanzapine inhibits voltage-dependent K(+) channels in coronary arterial smooth muscle cells","volume":"73","author":"Kang","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbrc.2025.151344_bib254","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2015.10.039","article-title":"Mechanism of inhibition by olanzapine of cloned hERG potassium channels","volume":"609","author":"Lee","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2025.151344_bib255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173027","article-title":"Inhibition by the atypical antipsychotic risperidone of voltage-dependent K(+) channels in rabbit coronary arterial smooth muscle cells","volume":"874","author":"An","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib256","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00210-017-1364-5","article-title":"Inhibition of cloned hERG potassium channels by risperidone and paliperidone","volume":"390","author":"Lee","year":"2017","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib257","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jat.4549","article-title":"Inhibition of voltage-dependent K(+) channels in rabbit coronary arterial smooth muscle cells by the atypical antipsychotic agent sertindole","volume":"44","author":"Zhuang","year":"2024","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.bbrc.2025.151344_bib258","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bcp.2005.10.047","article-title":"Block of hERG channel by ziprasidone: biophysical properties and molecular determinants","volume":"71","author":"Su","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151344_bib259","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbrc.2020.06.038","article-title":"The inhibitory effect of ziprasidone on voltage-dependent K(+) channels in coronary arterial smooth muscle cells","volume":"529","author":"An","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.151344_bib260","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2165\/00023210-200216110-00008","article-title":"Aripiprazole","volume":"16","author":"McGavin","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbrc.2025.151344_bib261","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.neuropharm.2006.11.008","article-title":"Differential agonist and inverse agonist profile of antipsychotics at D2L receptors coupled to GIRK potassium channels","volume":"52","author":"Heusler","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrc.2025.151344_bib262","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/1871527321666220324121935","article-title":"Mini review on cariprazine: a promising antipsychotic agent","volume":"22","author":"Patel","year":"2023","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.bbrc.2025.151344_bib263","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3390\/molecules23082087","article-title":"Current concepts and treatments of schizophrenia","volume":"23","author":"Stepnicki","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2025.151344_bib264","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-024-02531-7","article-title":"Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT(2A) receptor","author":"Gaitonde","year":"2024","journal-title":"Mol. Psychiatr."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T08:32:42Z","timestamp":1740385962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":264,"alternative-id":["S0006291X25000580"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151344","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct effects of antipsychotics on potassium channels","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151344"}}